New medicines in Alzheimer's fight
.
Alzheimer's Donation
Donate Online Now
.
University of Washington scientists have begun testing two new drugs they hope will ease the symptoms and possibly prolong the useful lives of Alzheimer's disease patients, a group that is destined to grow by multitudes in the decades to come. Researchers hope the drugs, which take a new approach to the disease, will do a better job than the current generation of medications that slow progression for only a few years. "Right now in Alzheimer's disease, these [two new] drugs are the great hope," said Dr. Elaine Peskind, associate director of the UW Alzheimer's Disease Research Center at the VA Puget Sound Health Care System in Seattle. One of the new medications seeks to remove the brain-altering plaque that partially causes Alzheimer's; the other is designed to prevent its production, Peskind said. UW testing new medicines in Alzheimer's fight
A Gardenia fruit extract traditionally used in Chinese medicine to treat the symptoms of type 2 diabetes does indeed contain a chemical that reverses some of the pancreatic dysfunctions that underlie the disease, researchers report in the June 7, 2006, Cell Metabolism. Click link to read more. http://www.medicalnewstoday.com/medicalnews.php?newsid=44667&nfid=al
The Hordaland Homocysteine Study: A Community-Based Study of ...International News Service - Sydney,Australia... outcome in patients with homocystinuria due to cystathionine beta-synthase deficiency ... repair in hippocampal neurons and sensitize them to amyloid toxicity in ...
Researchers target Alzheimer’s gene vaccineArizona State University - Tempe,USAA hallmark of Alzheimer's disease is the accumulation in the brain of the protein amyloid-beta 42. Scientists at the Biodesign Institute ...
The Hordaland Homocysteine Study: A Community-Based Study of ...International News Service - Sydney,Australia... outcome in patients with homocystinuria due to cystathionine beta-synthase deficiency ... repair in hippocampal neurons and sensitize them to amyloid toxicity in ...
Researchers target Alzheimer’s gene vaccineArizona State University - Tempe,USAA hallmark of Alzheimer's disease is the accumulation in the brain of the protein amyloid-beta 42. Scientists at the Biodesign Institute ...
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home